drugset / Trial / NCT01714089
Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether RNS60 is effective in the treatment of RR-MS compared to interferon beta-1a.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Interferon beta-1a | Protein / enzyme biologic | 30 ug | Intramuscular |
| Subject | RNS60 | Other / unclassified | 125 ml | Intravenous |
| Subject | RNS60 | Other / unclassified | 250 ml | Intravenous |